The cluster [Re6Se8I6]3− induces low hemolysis of human erythrocytes in vitro

Protectives effect of albumin

Edgardo Rojas-Mancilla, Alexis Oyarce, Viviana Verdugo, Zhiping Zheng, Rodrigo Ramírez-Tagle

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The cluster Re6Se8I63− has been shown to induce preferential cell death of a hepatic carcinoma cell line, thus becoming a promising anti-cancer drug. Whether this cluster induces acute hemolysis or if it interacts with albumin remains unclear. The effect of acute exposure of human red blood cells to different concentrations of the cluster with and without albumin is described. Red blood cells from healthy donors were isolated, diluted at 1% hematocrit and exposed to the cluster (25–150 µM) at 37 °C, under agitation. Hemolysis and morphology were analyzed at 1 and 24 h. The potential protection of 0.1% albumin was also evaluated. Exposition to therapeutic doses of the cluster did not induce acute hemolysis. Similar results were observed following 24 h of exposition, and albumin slightly reduced hemolysis levels. Furthermore, the cluster induced alteration in the morphology of red blood cells, and this was prevented by albumin. Together, these results indicate that the cluster Re6Se8I63− is not a hemolytic component and induces moderate morphological alterations of red blood cells at high doses, which are prevented by co-incubation with albumin. In conclusion, the cluster Re6Se8I63− could be intravenously administered in animals at therapeutic doses for in vivostudies.

Original languageEnglish (US)
Pages (from-to)1728-1735
Number of pages8
JournalInternational Journal of Molecular Sciences
Volume16
Issue number1
DOIs
StatePublished - Jan 13 2015

Fingerprint

hemolysis
erythrocytes
Hemolysis
albumins
Albumins
Blood
Erythrocytes
Cells
Cell death
dosage
Animals
cancer
hematocrit
Hematocrit
agitation
In Vitro Techniques
Hepatocytes
Cell Death
cultured cells
death

Keywords

  • Albumin
  • Cluster
  • Erythrocytes
  • Hemolysis

ASJC Scopus subject areas

  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Spectroscopy
  • Inorganic Chemistry
  • Catalysis
  • Molecular Biology
  • Computer Science Applications

Cite this

The cluster [Re6Se8I6]3− induces low hemolysis of human erythrocytes in vitro : Protectives effect of albumin. / Rojas-Mancilla, Edgardo; Oyarce, Alexis; Verdugo, Viviana; Zheng, Zhiping; Ramírez-Tagle, Rodrigo.

In: International Journal of Molecular Sciences, Vol. 16, No. 1, 13.01.2015, p. 1728-1735.

Research output: Contribution to journalArticle

Rojas-Mancilla, Edgardo ; Oyarce, Alexis ; Verdugo, Viviana ; Zheng, Zhiping ; Ramírez-Tagle, Rodrigo. / The cluster [Re6Se8I6]3− induces low hemolysis of human erythrocytes in vitro : Protectives effect of albumin. In: International Journal of Molecular Sciences. 2015 ; Vol. 16, No. 1. pp. 1728-1735.
@article{0111aeea75cb491691321c50706e84d6,
title = "The cluster [Re6Se8I6]3− induces low hemolysis of human erythrocytes in vitro: Protectives effect of albumin",
abstract = "The cluster Re6Se8I63− has been shown to induce preferential cell death of a hepatic carcinoma cell line, thus becoming a promising anti-cancer drug. Whether this cluster induces acute hemolysis or if it interacts with albumin remains unclear. The effect of acute exposure of human red blood cells to different concentrations of the cluster with and without albumin is described. Red blood cells from healthy donors were isolated, diluted at 1{\%} hematocrit and exposed to the cluster (25–150 µM) at 37 °C, under agitation. Hemolysis and morphology were analyzed at 1 and 24 h. The potential protection of 0.1{\%} albumin was also evaluated. Exposition to therapeutic doses of the cluster did not induce acute hemolysis. Similar results were observed following 24 h of exposition, and albumin slightly reduced hemolysis levels. Furthermore, the cluster induced alteration in the morphology of red blood cells, and this was prevented by albumin. Together, these results indicate that the cluster Re6Se8I63− is not a hemolytic component and induces moderate morphological alterations of red blood cells at high doses, which are prevented by co-incubation with albumin. In conclusion, the cluster Re6Se8I63− could be intravenously administered in animals at therapeutic doses for in vivostudies.",
keywords = "Albumin, Cluster, Erythrocytes, Hemolysis",
author = "Edgardo Rojas-Mancilla and Alexis Oyarce and Viviana Verdugo and Zhiping Zheng and Rodrigo Ram{\'i}rez-Tagle",
year = "2015",
month = "1",
day = "13",
doi = "10.3390/ijms16011728",
language = "English (US)",
volume = "16",
pages = "1728--1735",
journal = "International Journal of Molecular Sciences",
issn = "1422-0067",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "1",

}

TY - JOUR

T1 - The cluster [Re6Se8I6]3− induces low hemolysis of human erythrocytes in vitro

T2 - Protectives effect of albumin

AU - Rojas-Mancilla, Edgardo

AU - Oyarce, Alexis

AU - Verdugo, Viviana

AU - Zheng, Zhiping

AU - Ramírez-Tagle, Rodrigo

PY - 2015/1/13

Y1 - 2015/1/13

N2 - The cluster Re6Se8I63− has been shown to induce preferential cell death of a hepatic carcinoma cell line, thus becoming a promising anti-cancer drug. Whether this cluster induces acute hemolysis or if it interacts with albumin remains unclear. The effect of acute exposure of human red blood cells to different concentrations of the cluster with and without albumin is described. Red blood cells from healthy donors were isolated, diluted at 1% hematocrit and exposed to the cluster (25–150 µM) at 37 °C, under agitation. Hemolysis and morphology were analyzed at 1 and 24 h. The potential protection of 0.1% albumin was also evaluated. Exposition to therapeutic doses of the cluster did not induce acute hemolysis. Similar results were observed following 24 h of exposition, and albumin slightly reduced hemolysis levels. Furthermore, the cluster induced alteration in the morphology of red blood cells, and this was prevented by albumin. Together, these results indicate that the cluster Re6Se8I63− is not a hemolytic component and induces moderate morphological alterations of red blood cells at high doses, which are prevented by co-incubation with albumin. In conclusion, the cluster Re6Se8I63− could be intravenously administered in animals at therapeutic doses for in vivostudies.

AB - The cluster Re6Se8I63− has been shown to induce preferential cell death of a hepatic carcinoma cell line, thus becoming a promising anti-cancer drug. Whether this cluster induces acute hemolysis or if it interacts with albumin remains unclear. The effect of acute exposure of human red blood cells to different concentrations of the cluster with and without albumin is described. Red blood cells from healthy donors were isolated, diluted at 1% hematocrit and exposed to the cluster (25–150 µM) at 37 °C, under agitation. Hemolysis and morphology were analyzed at 1 and 24 h. The potential protection of 0.1% albumin was also evaluated. Exposition to therapeutic doses of the cluster did not induce acute hemolysis. Similar results were observed following 24 h of exposition, and albumin slightly reduced hemolysis levels. Furthermore, the cluster induced alteration in the morphology of red blood cells, and this was prevented by albumin. Together, these results indicate that the cluster Re6Se8I63− is not a hemolytic component and induces moderate morphological alterations of red blood cells at high doses, which are prevented by co-incubation with albumin. In conclusion, the cluster Re6Se8I63− could be intravenously administered in animals at therapeutic doses for in vivostudies.

KW - Albumin

KW - Cluster

KW - Erythrocytes

KW - Hemolysis

UR - http://www.scopus.com/inward/record.url?scp=84921275613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921275613&partnerID=8YFLogxK

U2 - 10.3390/ijms16011728

DO - 10.3390/ijms16011728

M3 - Article

VL - 16

SP - 1728

EP - 1735

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1422-0067

IS - 1

ER -